Evidence map›Paper›PMID 31989054›Full record

ArticleHeliyon2020

The serum concentration of βCGRP is novel marker for type 1 diabetes.

Yong Chen, Yunfeng Lin, Jingwen Wang, Xinxin Guo, Yujia Guo, Feng Dong, Feng Gao, Qicai Liu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yong ChenDepartment of Laboratory Medicine, Mindong Hospital, Fujian Medical University, Fuan, 355000, China.
Yunfeng LinDivision of Neonatology, Fujian Maternal and Child Health Hospital; Fujian Medical University, Fuzhou, China.
Jingwen WangDepartment of Pathology, 1st Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, China.
Xinxin GuoDepartment of Reproductive Medicine Centre, 1st Affiliated Hospital; Fujian Medical University, Fuzhou, China.
Yujia GuoDepartment of Reproductive Medicine Centre, 1st Affiliated Hospital; Fujian Medical University, Fuzhou, China.
Feng DongDepartment of Radiotherapy, 1st Affiliated Hospital; Fujian Medical University, Fuzhou, China.
Feng GaoDepartment of Pathology, 1st Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, China.
Qicai LiuDepartment of Reproductive Medicine Centre, 1st Affiliated Hospital; Fujian Medical University, Fuzhou, China.
Fujian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveDysregulation of neuropeptides, such as calcitonin gene-related peptide (CGRP) is thought to play significant roles in diabetes. In the present study, we investigated the importance of beta-calcitonin gene related peptide (βCGRP,

methodsThere were fifty-eight patients with T1D and 320 age and gender-matched healthy controls in Chinese Han population were included, the genotypes of

resultsAmong the SNPs genotyped, the C allele of

conclusionOur findings indicate that the presence of βCGRP is a probable molecular basis for the initial events triggered in T1D.

Indexed as

CALCBClinical geneticsEndocrinologyLaboratory medicinePathologyT1DβCGRP

Identifiers

PMID31989054
PMCPMC6970168
OpenAlexW3000036094

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.